Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 39 Projects
Project # Contact PI Funding Organization Fiscal Year
In Vivo Characterization of a GABA-A alpha-5 Positive Allosteric Modulator
GC-201907-2019284 ROSENZWEIG-LIPSON, SHARON Alzheimer's Drug Discovery Foundation 2019
5th Annual Goodes Prize for Excellence in Alzheimer’s Drug Discovery: Rasagiline Rescue in Alzheimer’s Disease Clinical Trial (R2 Trial) – Biomarker add-on funding
GC-201908-2019444 Cummings, Jeffrey Alzheimer's Drug Discovery Foundation 2019
Preclinical Development of an Antibody Therapeutic and an Imaging Agent Targeting Fibrin-Mediated Neuroinflammation
GC-201910-2019662 Spack, Edward Alzheimer's Drug Discovery Foundation 2019
Cholesterol-metabolizing enzyme CYP46A1 as a new therapeutic target for Alzheimer's disease
GC-2012681 Pikuleva, Irina Alzheimer's Drug Discovery Foundation 2016
Identification of small molecules that modulate microglia/macrophage uptake in primary human cells
GC-2012744 Bradshaw, Elizabeth Alzheimer's Drug Discovery Foundation 2016
Long-Term Nicotine Treatment of Mild Cognitive Impairment (MCI)
GC-2012756 Newhouse, Paul Alzheimer's Drug Discovery Foundation 2016
Phase 1 First-in-Human Multiple Ascending Dose Study of the Putative Cognitive Enhancer and M1 Positive Allosteric Modulator VU0467319
GC-2012786 Newhouse, Paul Alzheimer's Drug Discovery Foundation 2016
Treatment strategies based on enhancing dopamine release from noradrenergic axons.
GC-2012811 Lisman, John Alzheimer's Drug Discovery Foundation 2016
Clinical development of a companion marker for treatment with the dual LSD1/MAO-B inhibitor ORY-2001
GC-2012832 Maes, Tamara Alzheimer's Drug Discovery Foundation 2016
Discovery and preclinical development of isoform selective JNK inhibitors for Alzheimer's disease
GC-2012845 YOON, SUNG OK Alzheimer's Drug Discovery Foundation 2016